IDO-1 is a rate-limiting metabolic enzyme of the kynurenine pathway composed of several neuroactive metabolites including QUIN, an endogenous N-methyl-D-aspartate receptor (NMDAR) agonist implicated in depression and cognitive deficits (6, 40). This evidence concerns the gene IDO1 and Cognitive impairment.